 | Up a level |
Müller, Arndt-Christian; Aebersold, Daniel M; Albrecht, Clemens; Böhmer, Dirk; Flentje, Michael; Ganswindt, Ute; Ghadjar, Pirus; Schmidt-Hegemann, Nina-Sophie; Höcht, Stefan; Hölscher, Tobias; Niehoff, Peter; Pinkawa, Michael; Sedlmayer, Felix; Wolf, Frank; Zamboglou, Constantinos; Zips, Daniel; Wiegel, Thomas (2022). Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases. Strahlentherapie und Onkologie, 198(8), pp. 683-689. Springer 10.1007/s00066-022-01961-y
Shelan, Mohamed; Aebersold, Daniel M.; Albrecht, Clemens; Böhmer, Dirk; Flentje, Michael; Ganswindt, Ute; Höcht, Stefan; Hölscher, Tobias; Müller, Arndt-Christian; Niehoff, Peter; Pinkawa, Michael; Schmidt-Hegemann, Nina-Sophie; Sedlmayer, Felix; Wolf, Frank; Zamboglou, Constantinos; Zips, Daniel; Wiegel, Thomas; Ghadjar, Pirus (2021). Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO). Strahlentherapie und Onkologie, 197(11), pp. 993-1000. Springer 10.1007/s00066-021-01820-2
Pinkawa, Michael; Aebersold, Daniel M.; Böhmer, Dirk; Flentje, Michael; Ghadjar, Pirus; Schmidt-Hegemann, Nina-Sophie; Höcht, Stefan; Hölscher, Tobias; Müller, Arndt-Christian; Niehoff, Peter; Sedlmayer, Felix; Wolf, Frank; Zamboglou, Constantinos; Zips, Daniel; Wiegel, Thomas (2021). Radiotherapy in nodal oligorecurrent prostate cancer. Strahlentherapie und Onkologie, 197(7), pp. 575-580. Springer 10.1007/s00066-021-01778-1
Wolf, Frank; Sedlmayer, Felix; Aebersold, Daniel; Albrecht, Clemens; Böhmer, Dirk; Flentje, Michael; Ganswindt, Ute; Ghadjar, Pirus; Höcht, Stefan; Hölscher, Tobias; Müller, Arndt-Christian; Niehoff, Peter; Pinkawa, Michael; Schmidt-Hegemann, Nina-Sophie; Zamboglou, Constantinos; Zips, Daniel; Wiegel, Thomas (2021). Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer. Strahlentherapie und Onkologie, 197(2), pp. 89-96. Springer 10.1007/s00066-020-01723-8
